Hybrid Natural Product Derivatives for Anticancer and Antimalarial Applications

Hybrid natural product derivatives represent a frontier in the search for new therapies against cancer and malaria by combining distinct bioactive scaffolds into single molecular entities. Building on the success of artemisinin and its semi-synthetic derivatives as potent antimalarials, researchers have adopted a molecular hybridisation strategy to link endoperoxide-containing frameworks with other pharmacophores such as quinolines, fluoroquinolones, isatins and heterocyclic linkers. This covalent fusion can enhance target engagement, overcome resistance mechanisms and improve pharmacokinetic properties. In the anticancer arena, hybrid constructs aim to disrupt multiple signalling pathways—often through dual or multitarget modes of action—thereby reducing the likelihood of tumour escape. For malaria, bitopic ligands that simultaneously engage heme detoxification pathways and other parasite vulnerabilities hold promise for activity against drug-resistant Plasmodium strains and transmission-blocking potential. Advances in formulation science, notably nanoemulsion and nanoparticulate carriers, further address limitations of solubility and bioavailability. Collectively, these hybrid derivatives exemplify a rational design paradigm that merges natural product diversity with synthetic innovation to address two of the world’s most pressing health challenges.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Hybrid Natural Product Derivatives for Anticancer and Antimalarial Applications publication trend

The graph below shows the total number of articles in hybrid natural product derivatives for anticancer and antimalarial applications across all publications each year (not limited to Nature Index journals).

Technical terms

Hybrid natural product derivative: A compound formed by covalent linkage of two or more distinct natural-product-derived pharmacophores to create a single bioactive entity.

Pharmacophore: The spatial arrangement of steric and electronic features in a molecule necessary to ensure optimal interactions with a specific biological target.

Endoperoxide bridge: A peroxide linkage (–O–O–) within a cyclic framework, critical to the antimalarial activity of artemisinin derivatives through generation of reactive oxygen species.

Structure–activity relationship (SAR): The correlation between chemical structure variations and changes in biological activity, guiding rational drug design.

Selectivity index: The ratio between a compound’s cytotoxic concentration to healthy cells and its effective concentration against a target pathogen or tumour, indicating therapeutic window.

References

1. Synthesis of Novel Artemisinin, Ciprofloxacin, and Norfloxacin Hybrids with Potent Antiplasmodial Activity. Antibiotics (2024).
2. Synthesis and Characterization of Dimeric Artesunate Glycerol Monocaprylate Conjugate and Formulation of Nanoemulsion Preconcentrate. Molecules (2023).
3. Two-carbon tethered artemisinin–isatin hybrids: design, synthesis, anti-breast cancer potential, and in silico study. Frontiers in Molecular Biosciences (2023).
4. Design, Synthesis and Anti-Lung Cancer Evaluation of 1, 2, 3-Triazole Tethered Dihydroartemisinin-Isatin Hybrids. Frontiers in Pharmacology (2021).